|
Novo Nordisk A/S
Novo Nordisk Pharmaceutical Industries, Inc. (NNPII) in Clayton, NC is a manufacturing unit within Novo Nordisk A/S. Headquartered in Denmark and represented in 79 countries on five continents, Novo Nordisk A/S employs more than 25,000 people worldwide. Production sites include: Denmark, France, China, Japan, Brazil and the United States. We are number 1 in the world in diabetes sales and volume.
Novo Nordisk A/S is a focused healthcare company. With the broadest diabetes product portfolio in the industry, we are a world leader in diabetes care. In addition, Novo Nordisk A/S has a leading position within haemostasis management, growth disorders and hormone replacement therapy.
Our production is based on biotechnology; fermentation is the basis of our pharmaceuticals, using genetically modified microorganisms.
In 2006, Novo Nordisk A/S reported sales increased by 15% to DKK 38,743 million. We market our products in 179 countries.
|
